Antibiotic use and antimicrobial resistance remain stable Antibiotic resistance in the Netherlands remained stable in 2021 compared with the five previous years. This is evident from the 2022 annual NethMap/MARAN report.
Nearly twice as many cases involving long-term symptoms after COVID-19 Three months after infection with the coronavirus SARS-CoV-2, almost half of people still report one or more long-term symptoms, such as fatigue, difficulty concentrating and loss of smell.
Many more infections, limited increase in hospital admissions In the past week, the number of people who tested positive for COVID-19 in the Netherlands increased by 64% compared to the week before that.
Launch of Integrated Health Monitor COVID-19: large-scale study on public health impact of COVID-19 RIVM, the collective Municipal Public Health Services (GGDs) in collaboration with GGD GHOR, the NIVEL Netherlands Institute for Health Services Research and ARQ National Psychotrauma Centre have developed a new monitor: the Integrated Health Monitor
Insight into hospital admissions for acute respiratory infections In order to achieve an accurate overview of how often respiratory infections occur in the Netherlands, it is important to know how many patients are admitted to hospital with a respiratory infection.
Staying 1.5 metres apart is growing more difficult Staying 1.5 metres apart seems to be more and more difficult for people to manage.
Mortality still significantly elevated between 30 April and 6 May, but much lower than in previous weeks The total mortality rate in the Netherlands was significantly elevated in the week of 30 April to 6 May 2020. However, excess mortality was much lower than in previous weeks.
The 1.5-metre society is difficult to maintain Personal hygiene measures, such as not shaking hands, or using paper tissues, are not considered a problem by most Dutch people.
COVID-19 in nursing homes is stabilising The number of new nursing homes with COVID-19 patients is stabilising.
Rapid diagnostic tests are not reliable The Serology Task Force of the National Coordination Centre for Testing Capacity – a partnership between RIVM, hospitals and laboratories – has collected research results on rapid diagnostic tests